Supply of the Croatian market with antitoxin for counteracting the effects of the black widow spider venom
11.08.2014
In the Republic of Croatia there are no medicinal products containing immunoglobulin-antitoxin for counteracting the effects of black widow spider venom which have been granted a marketing authorisation. For emergency treatments of patients in the Republic of Croatia, the Agency for Medicinal Products and Medical Devices (HALMED) grants approval for entry/import of medicinal product without marketing authorization.
In line with the legal requirements, obliging the wholesalers to ensure a suitable and continuous supply of medicinal products within the limits of their responsibilities, HALMED has received a wholesaler request for the import of the antitoxin for counteracting the effects of the black widow spider venom of the manufacturer Merck Sharp & Dohme Corp., USA. HALMED has promptly granted approval for import, and the delivery is currently in progress.
HALMED will continue to monitor the supply of the Croatian market with antitoxin for counteracting the effects of the black widow spider venom and will promptly inform the public on all new information.
